Picking stocks at small cap stage for potential 100x. Medical field.
California, USA
Joined October 2012
- Tweets42.8K
- Following2K
- Followers16.1K
- Likes135K
Trav retweeted
Bobby Fischer
Henry Ford
Martin Luther
Walt Disney
Hitler
These "people" want you to think Henry Ford was a basement incel and not the inventor of modern production (read "The International Jew")
Seven new products will be available soon from $HIMS including- Sermorelin, Glutathione, B12, NAD+, L-carnitine, BPC-157 and TB-500.
Yesterday, HHS issued a draft interim policy that opened a safer, regulated path for peptides including BPC-157 and TB-500. This is a big step forward for access to innovation for more people, and over the last 2 years, we’ve been investing in the domestic infrastructure necessary for this exact moment.
With Peptides+, clinician-led protocols built by the experts in the field plus a world-class infrastructure comes together in the one of the only companies that can deliver quality access to these newly eligible treatments. Through our US based facilities, we’ll be able to offer eligible customers access to the newly allowed peptides made 100% from start to finish in the US, with ongoing clinical support and an entirely US-based supply chain they can trust.
Get an early look at what’s coming and sign up to be among the first in line to be in the know as we begin to roll this out: hims.com/peptides-plus
Important disclaimers here: news.hims.com/disclaimers/ca…
Get ready for the biggest windfall of customers ever seen to the $HIMS platform.
HHS just took a step toward the exact future that we’ve built for – bringing peptides out of the gray market, with clinician oversight and quality starting at the source. We’ve taken it one step further by building a US-based supply chain and infrastructure that our customers can trust.
This is encouraging progress. More to come.
“Rate limiting factor will be prescribers.”
When peptides hit the market, people will flock to the most reputable companies for distribution. $HIMS $ENHA
Soon, possibly within the next two weeks compounding pharmacies in the United States will be able to make the majority of the Peptides people want - legally.
I’m talking easily 500,000 to 1,000,000 bottles per week in a 503A compounding facility, like Strive, Empower, Olympia, ReviveRx etc
The infrastructure has been being built out for the past six months. They’ve confirmed to me personally.
The rate limiting factor will indeed be prescribers.
Hence @peptavo
